- Home
- MGRC vs KNSA Comparison
MGRC vs KNSA Comparison
Compare MGRC & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRC
- KNSA
- Stock Information
- Founded
- MGRC 1979
- KNSA 2015
- Country
- MGRC United States
- KNSA United Kingdom
- Employees
- MGRC N/A
- KNSA N/A
- Industry
- MGRC Diversified Commercial Services
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- MGRC Consumer Discretionary
- KNSA Health Care
- Exchange
- MGRC Nasdaq
- KNSA Nasdaq
- Market Cap
- MGRC 3.1B
- KNSA 2.6B
- IPO Year
- MGRC N/A
- KNSA 2018
- Fundamental
- Price
- MGRC $122.50
- KNSA $37.07
- Analyst Decision
- MGRC Buy
- KNSA Strong Buy
- Analyst Count
- MGRC 2
- KNSA 6
- Target Price
- MGRC $145.50
- KNSA $40.83
- AVG Volume (30 Days)
- MGRC 115.9K
- KNSA 417.3K
- Earning Date
- MGRC 10-23-2025
- KNSA 10-28-2025
- Dividend Yield
- MGRC 1.57%
- KNSA N/A
- EPS Growth
- MGRC 117.49
- KNSA N/A
- EPS
- MGRC 10.26
- KNSA 0.07
- Revenue
- MGRC $941,536,000.00
- KNSA $529,332,000.00
- Revenue This Year
- MGRC $6.30
- KNSA $37.21
- Revenue Next Year
- MGRC $5.24
- KNSA $11.99
- P/E Ratio
- MGRC $12.07
- KNSA $558.18
- Revenue Growth
- MGRC 8.78
- KNSA 56.18
- 52 Week Low
- MGRC $95.50
- KNSA $17.82
- 52 Week High
- MGRC $129.93
- KNSA $37.25
- Technical
- Relative Strength Index (RSI)
- MGRC 51.27
- KNSA 73.26
- Support Level
- MGRC $119.21
- KNSA $35.72
- Resistance Level
- MGRC $126.42
- KNSA $37.25
- Average True Range (ATR)
- MGRC 3.17
- KNSA 0.95
- MACD
- MGRC -0.03
- KNSA 0.14
- Stochastic Oscillator
- MGRC 42.86
- KNSA 94.31
About MGRC McGrath RentCorp
McGrath RentCorp is a rental company. It is comprised of four reportable business segments namely Modular building segment (Mobile Modular); Portable storage container segment (Portable Storage); Electronic test equipment segment (TRS-RenTelco); and its classroom manufacturing business selling modular buildings used as classrooms in California (Enviroplex). The company generates its revenues majorily from the rental of its equipment on operating leases with sales of equipment occurring in the normal course of business.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.